Cross-sectional Retrospective Study on Prescription Pattern of Antihypertensive Medication in Pregnant Women with Gestational Hypertension

Background: The most common pregnancy-related condition that still significantly contributes to mother and fetal morbidity and mortality is pregnancy induced hypertension. Aim of the study was to evaluate prescription pattern of gestational hypertension in pregnant women attending antenatal care Methodology: A retrospective cross sectional study was carried out in hospital for a period of 6 months to analyze the data from the year 2022-2024. Result:- Labetalol was the most prescribed medication for pregnant women with hypertension followed by a combination of labetalol+ nifedipine. Conclusion: Labetalol is a safe and effective medication that can be used more quickly to reduce blood pressure in pregnancy-induced hypertension. The excellent perinatal outcome in a disease usually associated with a high rate of maternal and fetal death and morbidity, together with the low incidence of maternal and fetal adverse effects, confirms its suitability for usage during pregnancy.